|
[1]NUEZ-GARCIA M, GOMEZ-SANTOS B, BUQUX, et al.Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver[J].J Lipid Res, 2017, 58 (9) :1903-1915.
|
|
[2]HAO C, CUI Y, OWEN S, et al.Human osteopontin:Potential clinical applications in cancer (Review) [J].Int J Mol Med, 2017, 39 (6) :1327-1337.
|
|
[3]HOAC B, NELEA V, JIANG W, et al.Mineralization-inhibiting effects of transglutaminase-crosslinked polymeric osteopontin[J].Bone, 2017, 101:37-48.
|
|
[4]ANUNOBI CC, KOLI K, SAXENA G, et al.Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms[J].Oncotarget, 2016, 7 (30) :48038-48049.
|
|
[5]FISHER LW, TORCHIA DA, FOHR B, et al.Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin[J].Biochem Biophys Res Commun, 2001, 280 (2) :460-465.
|
|
[6]FISHER LW, JAIN A, TAYBACK M, et al.Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers[J].Clin Cancer Res, 2004, 10 (24) :8501-8511.
|
|
[7]EL-TANANI MK.Role of osteopontin in cellular signaling and metastatic phenotype[J].Front Biosci, 2008, 13:4276-4284.
|
|
[8]DENHARDT DT, GUO X.Osteopontin:A protein with diverse functions[J].FASEB J, 1993, 7 (15) :1475-1482.
|
|
[9]CAO DX, LI ZJ, JIANG XO, et al.Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers[J].World J Gastroenterol, 2012, 18 (30) :3923-3930.
|
|
[10]WANG G, CHEN S, ZHAO C, et al.Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases[J].J Genet, 2016, 95 (3) :741-750.
|
|
[11]KLNING E, CHRISTENSEN B, BAJIC G, et al.Multiple low-affinity interactions support binding of human osteopontin to integrinαXβ2[J].Biochim Biophys Acta, 2015, 1854 (8) :930-938.
|
|
[12]CHEN Q, SHOU P, ZHANG L, et al.An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells[J].Stem Cells, 2014, 32 (2) :327-337.
|
|
[13]JIN Y, CHEN JN, FENG ZY, et al.OPN andαvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma[J].PLo S One, 2014, 9 (2) :e87930.
|
|
[14]ZHANG H, GUO M, CHEN JH, et al.Osteopontin knockdown inhibitsαv, β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/m TOR pathway[J].Cell Physiol Biochem, 2014, 33 (4) :991-1002.
|
|
[15]KALE S, RAJA R, THORAT D, et al.Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth viaα9β1 integrin[J].Oncogene, 2014, 33 (18) :2295-2306.
|
|
[16]GERICKE A, QIN C, SPEVAK L, et al.Importance of phosphorylation for osteopontin regulation of biomineralization[J].Calcif Tissue Int, 2005, 77 (1) :45-54.
|
|
[17]WANG KX, DENHARDT DT.Osteopontin:Role in immune regulation and stress responses[J].Cytokine Growth Factor Rev, 2008, 19 (5-6) :333-345.
|
|
[18]MIYAZAKI K, OKADA Y, YAMANAKA O, et al.Corneal wound healing in an osteopontin-deficient mouse[J].Invest Ophthalmol Vis Sci, 2008, 49 (4) :1367-1375.
|
|
[19]SUBRAMAN V, THIYAGARAJAN M, MALATHI N, et al.OPN-revisited[J].J Clin Diagn Res, 2015, 9 (6) :ZE10-13.
|
|
[20]WEI R, JPC W, KWOK HF.Osteopontin-a promising biomarker for cancer therapy[J].J Cancer, 2017, 8 (12) :2173-2183.
|
|
[21]TILLI TM, FRANCO VF, ROBBS BK, et al.Osteopontin-c splicing isoform contributes to ovarian cancer progression[J].Mol Cancer Res, 2011, 9 (3) :280-293.
|
|
[22]NG L, WAN TM, LAM CS, et al.Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer[J].PLo S One, 2015, 10 (5) :e0126219.
|
|
[23]STEINMAN L.A molecular trio in relapse and remission in multiple sclerosis[J].Nat Rev Immunol, 2009, 9 (6) :440-447.
|
|
[24]LI J, CHEN X, DAI M, et al.Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma:A metaanalysis[J].Clin Res Hepatol Gastroenterol, 2017, 41 (5) :543-553.
|
|
[25]JANG ES, JEONG SH, KIM JW, et al.Diagnostic performance of Alpha-fetoprotein, protein induced by vitamin K absence, Osteopontin, Dickkopf-1 and its combinations for hepatocellular carcinoma[J].PLo S One, 2016, 11 (3) :e0151069.
|
|
[26]CABIATI M, GAGGINI M, CESARE MM, et al.Osteopontin in hepatocellular carcinoma:A possible biomarker for diagnosis and follow-up[J].Cytokine, 2017, 99:59-65.
|
|
[27]ABU EMMA, ABDEL-ALEEM A, ALI A, et al.Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma[J].Ann Hepatol, 2011, 10 (3) :296-305.
|
|
[28]SIMO A, MADALENO J, SILVA N, et al.Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening[J].BMC Gastroenterol, 2015, 15:73.
|
|
[29]ZHOU C, ZHOU HJ, ZHANG XF, et al.Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma[J].Ann Surg Oncol, 2013, 20 (3) :929-937.
|
|
[30]ZHAO J, DONG L, LU B, et al.Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis[J].Gastroenterology, 2008, 135 (3) :956-968.
|
|
[31]FAN X, HE C, JING W, et al.Intracellular osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis[J].Cancer Res, 2015, 75 (1) :86-97.
|
|
[32]YE QH, QIN LX, FORGUES M, et al.Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning[J].Nat Med, 2003, 9 (4) :416-23.
|
|
[33]LIU XS.Experimental study of effect on biological behavior of hepatic cells by osteopontin and anti-sense osteopontin[D].Suzhou:Suzhou Univ, 2004. (in Chinese) 刘希胜.骨桥蛋白及其反义基因对肝癌细胞浸润的生物学行为实验研究[D].苏州:苏州大学, 2004.
|
|
[34]LIKUI W, HONG W, SHUWEN Z, et al.The potential of osteopontin as a therapeutic target for human colorectal cancer[J].JGastrointest Surg, 2011, 15 (4) :652-659.
|
|
[35]TRIERWEILER C, HOCKENJOS B, ZATLOUKAL K, et al.The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice[J].Cell Death Differ, 2016, 23 (4) :576-582.
|
|
[36]SUN BS, DONG QZ, YE QH, et al.Lentiviral-mediated miRNAagainst osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma[J].Hepatology, 2008, 48 (6) :1834-1842.
|
|
[37]SILVA I, RAUSCH V, SEITZ HK, et al.Does hypoxia cause carcinogenic iron accumulation in alcoholic liver disease (ALD) ?[J].Cancers (Basel) , 2017, 9 (11) :145.
|
|
[38]WANG C, HAN C, ZHANG Y, et al.LncRNA PVT1 regulate expression of HIF1αvia functioning as ceRNA for miR-199a-5p in non-small cell lung cancer under hypoxia[J].Mol Med Rep, 2017, 17 (1) :1105-1110.
|
|
[39]WANG CQ, SUN HT, GAO XM, et al.Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression[J].Am J Cancer Res, 2016, 6 (9) :1873-1889.
|
|
[40]HOLLENBACH M.The role of glyoxalase-I (Glo-I) , advanced glycation endproducts (AGEs) , and their receptor (RAGE) in chronic liver disease and hepatocellular carcinoma (HCC) [J].Int J Mol Sci, 2017, 18 (11) :2466.
|
|
[41]AWAN FM, NAZ A, OBAID A, et al.Identification of circulating biomarker candidates for hepatocellular carcinoma (HCC) :An integrated prioritization approach[J].PLo S One, 2015, 10 (9) :e0138913.
|
|
[42]ZHU W, GUO L, ZHANG B, et al.Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection[J].Ann Surg Oncol, 2014, 21 (4) :1304-1313.
|
|
[43]WAIDELY E, AL-YUOBI AR, BASHAMMAKH AS, et al.Serum protein biomarkers relevant to hepatocellular carcinoma and their detection[J].Analyst, 2016, 141 (1) :36-44.
|
|
[44]WITJES CD, van AALTEN SM, STEYERBERG EW, et al.Recently introduced biomarkers for screening of hepatocellular carcinoma:A systematic review and meta-analysis[J].Hepatol Int, 2013, 7 (1) :59-64.
|
|
[45]MARRERO JA, FENG Z, WANG Y, et al.Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma[J].Gastroenterology, 2009, 137 (1) :110-118.
|
|
[46]XU Z, LIU L, PAN X, et al.Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J].Medicine (Baltimore) , 2015, 94 (12) :e659.
|
|
[47]ZHANG J, ZHAO Y, YANG Q.Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma:Ameta-analysis[J].Int J Biol Markers, 2014, 29 (4) :e403-e410.
|
|
[48]MOHAMMADI S, GHAFFARI SH, SHAIEGAN M, et al.Curcumin veto the effects of Osteopontin (OPN) specific inhibitor on leukemic stem cell colony forming potential via promotion of OPN overexpression[J].Int J Hematol Oncol Stem Cell Res, 2016, 10 (3) :120-129.
|
|
[49]WU XL, LIN KJ, BAI AP, et al.Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells[J].World JGastroenterol, 2014, 20 (30) :10440-10448.
|
|
[50]GRBCˇIC'P, TOMLJANOVIC'I, KLOBUCˇAR M, et al.Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling[J].Biochem Biophys Res Commun, 2017, 487 (4) :782-788.
|
|
[51]PETROCCA F, LIEBERMAN J.Micromanipulating cancer:microRNA-based therapeutics?[J].RNA Biol, 2009, 6 (3) :335-340.
|
|
[52]QIN S, ZHANG Z, LI J, et al.FRZB knockdown upregulatesβ-catenin activity and enhances cell aggressiveness in gastric cancer[J].Oncol Rep, 2014, 31 (5) :2351-2357.
|
|
[53]LIN F, HUANG CM, CAO J, et al.Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells[J].Genet Mol Res, 2015, 14 (4) :14440-14447.
|
|
[54]LIU G, FAN X, TANG M, et al.Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells[J].Cancer Lett, 2016, 383 (2) :171-182.
|
DownLoad: